Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients

• Status: Completed
• Trial end date: 2009-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Green Tea Polyphenol, an extraction from Green Tea is effective and safe in the treatment of De Novo Parkinson's disease Patients without taking any antiparkinsonism drug

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xuanwu Hospital, Beijing
• Collaborators: Michael J. Fox Foundation for Parkinson's Research; Ministry of Health, China

Criteria

Inclusion Criteria:

• Willing and able to give informed consent

• Age 30 years or older at time of diagnosis of Parkinson's disease

• Diagnosed as having typical PD

• Parkinson's disease duration of no more than 5 years

• No current dopaminergic or other forms of anti-parkinsonism therapy

• Hoehn and Yahr stage < 3